Sionna Therapeutics
Investments
1
Lead Investments
0
Sionna Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel small molecule therapies to treat cystic fibrosis (CF). The company aims to revolutionize the treatment paradigm for CF patients by restoring CFTR function to as close to normal as possible.
Highlights
Focus Areas
Biotechnology
Genetics
Health Care
Medical
Pharmaceutical
Notable Investments